Platelet-rich plasma and stem cells in the treatment of desmopathy of the distal collateral ligaments in equine
Keywords:
Equine, PRP, MSCs, diagnosis, treatmentAbstract
Horses are animals widely used in sporting events and are therefore prone to accidents that can lead to joint and bone injuries. In the clinical routine, devices such as the use of X-ray and ultrasound are of great importance for the correct diagnosis to be made and the clinical conduct can be better planned. In addition, some biomaterials such as platelet-rich plasma (PRP) and mesenchymal stem cells (MSCs) have been included in the therapeutic protocols, demonstrating great effectiveness in the treatment of this type of injury due to the large amount of growth factors present in both biomaterials. PRP is a blood derivative, characterized by high platelet concentration. It is produced from two centrifugations, the first to separate plasma from red blood cells and the second to concentrate platelets. MSCs were isolated from adipose tissue, cultured, transported and applied autologously, as well as PRP. In the present report, an 8-year-old female Brazilian equestrian horse was diagnosed with desmopathy in the collateral ligaments of the distal interphalangeal joint and was treated with PRP and MSCs in an associated and sequential manner. A significant improvement in the clinical picture was found in comparison to the data found in the literature, demonstrating great potential of the associated use of PRP and MSCs in the treatment of ligament injuries.
References
AGGARWAL, S.; PITTENGER, M.F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood, v.105, n.4, p.1815-1822, 2005.
ANITUA, E.; ANDIA, I.; ARDANZA, B.; NURDEN, P.; NURDEN, A.T. Autologous platelet source of proteins for healing and tissue regeneration. Thrombosis and Haemostasis, v.91, n.1, p.4-15, 2004.
ANITUA, E.; SÁNCHEZ, M.; ORIVE, G. The potential impact of the preparation richin growth factors (PRGF) in different medical fields. Biomaterials, v.28, n.31, p.4551-4560, 2007.
BARBASH, I.M.; CHOURAQUI, P.; BARON, J.; FEINBERG, M.S.; ETZION, S.; TESSONE, A.; MILLER, L.; GUETTA, E.; ZIPORI, D.; KEDES, L. H.; KLONER, R.A.; LEOR, J. Systemic delivery of bone marrow–derived mesenchymal stem cells to the infarcted myocardium: Feasibility, Cell Migration and Body Distribution. Circulation, v.108, n.7, p.863-868, 2003.
BIEBACK, K.; WUCHTER, P.; BESSER, D.; FRANKE, W.; BECKER, M.; OTT, M.; PACHER, M.; MA, N.; STAMM, C.; KLUTER, H.; MULLER, A.; HO, A.D. Mesenchymal stromal cells (MSCs): science and f (r) iction. Journal of Molecular Medicine, v.90, n.7, p.773-782, 2012.
BITTENCOURT, M.K.W.; BARROS, M.A.; MARTINS, J.F.P.; VASCONCELLOS, J.P.C.; MORAIS, B.P.; POMPEIA, C.; BITTENCOURT, M.D., EVANGELHO, K.S.; KERKIS, I.; WENCESLAU, C.V. Allogeneic mesenchymal stem cell transplantation in dogs with keratoconjunctivitis sicca. Cell medicine, v.8, n.3, p.63-77, 2016.
BROECKX S.; ZIMMERMAN M.; CROCETTI S.; SULS, M.; MARIE, T.; FERGUSON, S.J.; CHIERS, K.; DUCHATEAU, L.; OBREGO-FRANCO, A.; WUERTZ, K.; SPAAS, J.H. Regenerative therapies for equine degenerative joint disease: a preliminary study. PLoS One, v.9, n.1, p.1-11, 2014.
BURNOUF, T.; GOUBRAN, H.A.; CHEN, T.M.; OU, K.L.; EL-EKIABY, M.; RADOSEVIC, M. Blood-derived biomaterials and platelet growthfactors in regenerative medicine. Elsevier, v.27, n.2, p.77-89, 2013.
CAPLAN, A.I.; CORREA, D. The MSC: an injury drugstore. Cell stem cell, v.9, n.1, p.11-15, 2011.
CARMONA, J.U.; LÓPEZA, C.; PRADESB, M. Uso de concentrados autólogos de plaquetas obtenidos mediante el método del tubo como tratamiento de artropatías en caballos. Archivos de Medicina Veterinária, v.41, n.2, p.175-179, 2009.
CARVALHO, A.M.; ALVES, A.L.G.; OLIVEIRA, P.G.G.; ALVAREZ, L.E.C.; LAUFER-AMORIM, R.; HUSSNI, C.A.; DEFFUNE, E. Use of adipose tissue-derived mesenchymal stem cells for experimental tendinitis therapy in equines. Journal Equine Veterinary Science. v.31, n.1, p.26–34, 2011.
DHURAT, R.; SUKESH, M.S. Principles and Methods of Preparation of Platelet-Rich Plasma: A Review and Author’s Perspective. Journal of Cutaneous And Aesthetic Surgery, v.7, n.4, p.189-197. 2014.
EVERTS, P.A.; KNAPE, J.T.; WEIBRICH, G.; SCHONBERGER, J.P.; HOFFMANN, J.; OVERDEVEST, E.P.; BOX, H.A.; VAN ZUNDERT, A. Platelet-rich plasma and platelet gel: a review Journal of Extra-Corporeal Technology, v.38, n.2, p.174-187, 2006.
KANG, S.K.; SHIN, S.; KO, M.S.; JO, J.Y.; RA, J.C. Journey of mesenchymal stem cells for homing: strategies to enhance efficacy and safety of stem cell therapy. Stem cells international, v.2012, n.342968, p.1-11, 2012.
KUSHIDA, S.; KAKUDO, N.; MORIMOTO, N.; HARA, T.; OGAWA, T.; MITSUI, T.; KUSUMOTO, K. Platelet and growth factor concentrations in activated platelet-rich plasma: a comparison of seven commercial separation systems. Journal of Artificial Organs, v.17, n.2, p.186-192, 2014.
LAITINEN A.; OJA, S.; KILPINEN, L.; KAARTINEN, T.; MOLLER, J.; LAITINEN, S.; KORHONEN, M.; NYSTEDT, J. A robust and reproducible animal serum-free culture method for clinical-grade bone marrow-derived mesenchymal stromal cells. Cytotechnology, v.68, n.4, p.891-906, 2016.
MALHOTRA, A.; PELLETIER, M.H.; YU, Y.; WALSH, W.R. Can platelet-rich plasma (PRP) improve bone healing? A comparison between the theory and experimental outcomes. Archives of Orthopaedic and Trauma Surgery. v.133, n.2, p.153-165, 2013.
MELESHINA A.V.; CHERKASOVA E.I.; SHIRMANOVA M.V.; KLEMENTIEVA N.V.; KISELEVA E.V.; SNOPOVA L.B.; PRODANETS N.N.; ZAGAYNOVA E.V. Influence of mesenchymal stem cells on metastasis development in mice in vivo. Stem cell research & therapy, v.6, n.1, p.15, 2015.
MEIRELLES, L.S.; CAPLAN A.I.; NARDI N.B. In search of the in vivo identity of mesenchymal stem cells. Stem Cells, v.26, p.2287-2299, 2008.
MONTEIRO, B.S.; ARGÔLO-NETO, N.M.; DEL CARLO, R.J. Terapia celular em reparação óssea – aplicação clínica de células-tronco mesenquimais. Ciência Veterinária nos Trópicos, v.11, n.2, p.95-100, 2008.
NIXON, A.J.; DAHLGREN, L.A.; HAUPT, J.L.; YEAGER, A.E.; WARD, D.L. Effect of adipose-derived nucleated cell fractions on tendon repair in horses with collagenase-induced tendinitis. American Journal of Veterinary Research, v.69, n.7, p.928- 937, 2008.
ORSI, P.R.; LANDIM-ALVARENGA, F.C.; JUSTULIN JR, L.A.; KANENO, R.; GOLIM, M.A.; DOS SANTOS, D.C.; CREST, C.F.Z.; OBA, E.; MAIA, L.; BARRAVIERA, B.; FERREIRA JR, R.S. A unique heterologous fibrin sealant (HFS) as a candidate biological scaffold for mesenchymal stem cells in osteoporotic rats. Stem Cell Research & Therapy, v.8, n.1, p.1-14. 2017.
PITTENGER, M.F.; MACKAY, A.M.; BECK, S.C.; JAISWAL, R.K.; DOUGLAS, R.; MOSCA, J.D.; MOORMAN, M.A.; SIMONETTI, D.W.; CRAIG, S.; MARSHAK, D.R. Multilineage potential of adult human mesenchymal stem cells. Science, v.284, n.5411, p.143-147, 1999.
PORTAL, B.A.R. Disfunção sacroilíaca equina. 2016. 38p. (Dissertação de Mestrado em Medicina Veterinária). Instituto de Ciências Biomédicas Abel Salazar da Universidade do Porto, 2016.
RABBA, S.; BOLEN, G.; VERWILGHEN, D.; SALCICCIA, A.; BUSONI, V. Ultrasonographic findings in horses with foot pain but without radiographically detectable osseous abnormalities. Veterinaty Radiology Ultrasound, v.52, p.95-102, 2011.
RICHARDSON, L.E.; DUDHIA, J.; CLEGG, P.D.; SMITH, R. Stem cells in veterinary medicine attempts at regenerative equine tendon after injury. Trends Biotechnology, v.25, n.9, p.409-416, 2007.
RUBIO, D.; GARCIA-CASTRO, J.; MARTÍN, M.C.; DE LA FUENTE, R.; CIGUDOSA, J.C.; LLOYD, A.C.; BERNAD, A. Spontaneous human adult stem cell transformation. Cancer Research, v.65, n.8, p.3035–6682, 2005.
SENZEL, L.; GNATENKO, D.V.; BAHOU, W.F. The platelet proteome. Current Opinion in Hematology, p.329-333, 2009.
SORRELL, J.M; ABER, M.A.; CAPLAN, A.I. Influence of adult mesenchymal stem cells on in vitro vascular formation. Tissue Engineering Part A, v.15, n.7, p.1751-1761, 2009.
SWANSON, T.D. Lameness grading system. In: Guide for Veterinary Service and Judging of Equestrian Events. American Association of Equine Practitioners. 3ª ed., Golden, CO, 1984. 24p.
TURNER, T.A.; SAGE, A.M. Desmitis of Distal Interphalangeal Collateral Ligaments: 22 Cases. Comunicação apresentada no 48th Annual Convention of the American Association of Equine Practioners. Florida, EUA, p.343-346, 2002.
WAHL, E.A.; FIERRO, F.A.; PEAVY, T.R.; HOPFNER, U.; DYE, J.F.; MACHENS, H.G.; EGAÑA, J.T.; SCHENCK, T.L. In vitro evaluation of scaffolds for the delivery of mesenchymal stem cells to wounds. BioMed Research International, v.2015, p.1-14, 2015.
YAMADA A.L.M. Efeito do implante autólogo de plasma rico em plaquetas (PRP) e células tronco mesenquimais na reparação de lesões condrais articulares induzidas experimentalmente em equinos. 2011. 111p. (Dissertação de Mestrado), Faculdade de Medicina Veterinária e Zootecnia, Universidade Estadual Paulista, Botucatu, SP, 2011.
ZHOU, Y.; ZIMBER, M.; HUIHUA, Y.; NAUGHTON, G.K.; FERNAN, R.; LI, W.J. Effects of human fibroblast-derived extra cellular matrix on mesenchymal stem cells. Stem Cell Reviews and Reports, v.12, n.5, p.560-572, 2016.
